AJOVista LLC Takes $68,000 Position in Accolade, Inc. (NASDAQ:ACCD)

AJOVista LLC bought a new stake in Accolade, Inc. (NASDAQ:ACCD) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 5,645 shares of the company’s stock, valued at approximately $68,000.

Several other institutional investors have also recently added to or reduced their stakes in the stock. JFG Wealth Management LLC acquired a new position in shares of Accolade during the fourth quarter worth $5,657,000. Certuity LLC purchased a new stake in Accolade in the fourth quarter valued at $603,000. Knights of Columbus Asset Advisors LLC lifted its position in Accolade by 100.0% in the fourth quarter. Knights of Columbus Asset Advisors LLC now owns 54,124 shares of the company’s stock valued at $650,000 after acquiring an additional 27,062 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Accolade by 39.0% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 16,584 shares of the company’s stock valued at $199,000 after acquiring an additional 4,656 shares during the last quarter. Finally, International Assets Investment Management LLC raised its holdings in shares of Accolade by 1,101.0% in the fourth quarter. International Assets Investment Management LLC now owns 110,492 shares of the company’s stock valued at $1,327,000 after buying an additional 101,292 shares during the last quarter. Institutional investors and hedge funds own 84.99% of the company’s stock.

Accolade Trading Up 3.9 %

Shares of ACCD stock traded up $0.28 during trading hours on Friday, hitting $7.54. The company’s stock had a trading volume of 677,665 shares, compared to its average volume of 778,971. The company has a quick ratio of 2.35, a current ratio of 2.64 and a debt-to-equity ratio of 0.47. The business has a fifty day moving average of $9.30 and a 200-day moving average of $9.93. Accolade, Inc. has a twelve month low of $6.33 and a twelve month high of $15.36.

Accolade (NASDAQ:ACCD) last announced its quarterly earnings data on Thursday, April 25th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.01. The business had revenue of $124.80 million for the quarter, compared to the consensus estimate of $123.91 million. Accolade had a negative net margin of 24.09% and a negative return on equity of 22.53%. The company’s quarterly revenue was up 26.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.42) earnings per share. On average, equities analysts expect that Accolade, Inc. will post -1.24 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on ACCD. Truist Financial reduced their target price on shares of Accolade from $16.00 to $14.00 and set a “buy” rating for the company in a report on Friday, April 26th. Canaccord Genuity Group reduced their target price on shares of Accolade from $18.00 to $16.00 and set a “buy” rating for the company in a report on Friday, April 26th. Wells Fargo & Company reduced their target price on shares of Accolade from $12.00 to $10.00 and set an “equal weight” rating for the company in a report on Tuesday, April 30th. Barclays dropped their price target on shares of Accolade from $13.00 to $11.00 and set an “equal weight” rating on the stock in a research note on Friday, April 26th. Finally, Stifel Nicolaus dropped their price target on shares of Accolade from $15.00 to $13.00 and set a “buy” rating on the stock in a research note on Monday, April 22nd. Four research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, Accolade presently has a consensus rating of “Moderate Buy” and a consensus price target of $14.57.

Accolade Profile

Accolade, Inc, together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians.